Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
Cell Reports|July 5, 2024
Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosisYanquan Zhang, Ka-Wing Fong, Fengyi Mao, et al.Cancer Cytopathology|May 31, 2022
Multi-institutional validation of a modified scheme for subcategorizing salivary gland neoplasm of uncertain malignant potential (SUMP)Jen-Fan Hang, Jaslyn Jie Lin Lee, Min En Nga, et al.Biorxiv : the Preprint Server for Biology|June 6, 2025
PLK1-mediated phosphorylation of PHGDH reprograms serine metabolism in advanced prostate cancerXiongjian Rao, Derek B Allison, Robert M Flight, et al.JCO Precision Oncology|September 14, 2022
Molecular Tumor Board-Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical TrialRachel W Miller, Megan L Hutchcraft, Heidi L Weiss, et al.Plos Genetics|November 21, 2023
Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signalingChaohao Li, Derek B Allison, Daheng He, et al.Cancer Research|August 11, 2022
Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint TherapyZhuangzhuang Zhang, Lijun Cheng, Jie Li, et al.Cancers|May 13, 2023
A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate CancerZin W Myint, William H St Clair, Stephen E Strup, et al.Oncogene|February 16, 2025
GDP-mannose 4,6-dehydratase is a key driver of MYCN-amplified neuroblastoma core fucosylation and tumorigenesisBeibei Zhu, Michelle G Pitts, Michael D Buoncristiani, et al.Journal of the American Society for Mass Spectrometry|April 3, 2026
Mass Spectrometry-Based Spatial Imaging of the CochleaRoberto A Ribas, Qun Tang, Scarlett I Caffee, et al.EMBO Molecular Medicine|September 5, 2022
In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissuesLyndsay E A Young, Lindsey R Conroy, Harrison A Clarke, et al.Pageof 11